Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $1.49 billion. The enterprise value is $993.93 million.

Market Cap	1.49B
Enterprise Value	993.93M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 48.41 million shares outstanding.

Current Share Class	48.41M
Shares Outstanding	48.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+4.68%
Owned by Insiders (%)	2.39%
Owned by Institutions (%)	70.13%
Float	31.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.08
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.94, with a Debt / Equity ratio of 0.00.

Current Ratio	16.94
Quick Ratio	16.65
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-937.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-25.62%
Revenue Per Employee	n/a
Profits Per Employee	-$2.60M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+47.07%
50-Day Moving Average	26.35
200-Day Moving Average	15.79
Relative Strength Index (RSI)	61.69
Average Volume (20 Days)	403,693

Short Selling Information

The latest short interest is 5.25 million, so 10.84% of the outstanding shares have been sold short.

Short Interest	5.25M
Short Previous Month	5.21M
Short % of Shares Out	10.84%
Short % of Float	16.63%
Short Ratio (days to cover)	12.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.08M
Pretax Income	-109.24M
Net Income	-72.82M
EBITDA	-125.00M
EBIT	-125.08M
Earnings Per Share (EPS)	-$1.70

Full Income Statement

Balance Sheet

The company has $349.16 million in cash and $1.91 million in debt, giving a net cash position of $499.01 million or $10.31 per share.

Cash & Cash Equivalents	349.16M
Total Debt	1.91M
Net Cash	499.01M
Net Cash Per Share	$10.31
Equity (Book Value)	486.79M
Book Value Per Share	10.00
Working Capital	334.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$89.69 million and capital expenditures -$181,182, giving a free cash flow of -$89.87 million.

Operating Cash Flow	-89.69M
Capital Expenditures	-181,182
Free Cash Flow	-89.87M
FCF Per Share	-$1.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.88%
FCF Yield	-6.02%

Dividend Details

Analyst Forecast

The average price target for ORKA is $45.22, which is 46.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$45.22
Price Target Difference	46.63%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a